News
GWPH
--
0.00%
--
GW Pharma's Epidyolex approved in U.K. for seizures due to tuberous sclerosis complex
GW Pharmaceuticals, now part of Jazz Pharmaceuticals (NASDAQ:JAZZ) announces that the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a new indication for GW's cannabidiol (Epidyolex/Epidiolex) as an adjunctive treatment
Seekingalpha · 08/10 08:50
Does Big Business Provide A Better Look Into Cannabis Reform Than Capitol Hill? Operators Believe So.
Cannabis operators and executives tell Benzinga that the movement of private and public companies may serve as a better indicator of regulatory activity than the federal government. At the very least, they say that the industry has made advancements so far...
Benzinga · 07/29 13:20
Biotech M&A may heat up with potential targets Horizon Therapeutics, Arrowhead Pharma, analyst says
janiecbros/E+ via Getty Images Biotech M&A is poised to heat up again as shares of the SPDR S&P Biotech’s (XBI) have fallen about 25% from their February highs, according to
Seekingalpha · 07/11 13:00
Nextleaf Solutions Forges Unique Path in the Cannabis Industry with its IP Strategy
As the United States federal government continues to look at the option of national cannabis legalization, there are now only two states which haven't been given limited access. As a result of the U.S.
Benzinga · 07/07 12:48
Mid-size pharmaceutical firms lead bigger rivals in acquisitions this year
Zhanna Hapanovich/iStock via Getty Images Concerned over high premiums of targets, the large-cap pharmaceutical companies have taken a backseat in acquisitions this year as they focused on repayment of debt
Seekingalpha · 07/07 10:49
The Week In Cannabis: Justice Clarence Thomas, Mexico's Decriminalization, Apple's Policy Changes, Tilray And More
Below is a recap of the main news related to the cannabis industry and markets for the week of June 28, 2021.
Benzinga · 07/06 20:04
A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies (Updated)
As the cannabis industry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ. The club, however, remains relatively small.
Benzinga · 07/02 18:22
Jazz updates 2021 financial guidance to reflect impact of GW Pharma acquisition
Zhanna Hapanovich/iStock via Getty Images Jazz Pharmaceuticals (JAZZ) estimates ~18.1% of additional revenue in 2021 following the acquisition of GW Pharmaceuticals (GWPH), the updated financial guidance issued by the company for
Seekingalpha · 06/17 12:48
Cannabis investors Discuss Strategies For 2021 In The Context Of Consolidation And Interstate Commerce
2021 seems to be the year of cannabis, as its prospects and apparent societal acceptance have dramatically changed since the industry’s early days. How are investors navigating this complex and ever-shifting landscape as we sit on the verge of federal lega...
Benzinga · 06/09 18:39
A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies
As the cannabis industry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ. The club, however, remains relatively small.
Benzinga · 05/14 18:21
The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More
This was an eventful week for the cannabis industry.
Benzinga · 05/11 16:38
Jazz Pharmaceuticals Closes On Acquisition Of GW Pharma, Adds CBD Drug Epidiolex To Portfolio
The biopharmaceutical company Jazz Pharmaceuticals (NASDAQ: JAZZ), has finalized the acquisition of the cannabinoid drug company GW Pharmaceuticals plc. (NASDAQ: GWPH).
Benzinga · 05/06 14:16
CBD Oil Extract Market Share Projected To Reach $25.57 Billion by 2027
, /PRNewswire/ -- The CBD Oil extract market is growing but what exactly is making it grow? Recent reports indicate that it is the increasing preferences of oil and tinctures extracted from cannabis which is primarily driving the market growth rate. Out o...
PR Newswire - PRF · 05/06 13:15
Jazz closes acquisition of GW Pharmaceuticals
Jazz Pharmaceuticals (JAZZ) has officially closed its $7.2B acquisition of GW Pharmaceuticals plc (GWPH).GW shareholders gave the thumbs up to the deal last month.With the acquisition, Jazz gains access to
Seekingalpha · 05/05 13:29
Study: U.K. Cannabis Industry Could Be Worth $2.8B Per Year If These Problems Are Fixed
A new research paper is shining light on the outdated laws and regulations currently hindering the U.K.’s CBD and medicinal cannabis industries. Written by Maple Tree Consultants and Mackrell. Solicitors, the paper is supported by sixteen industry heavywei...
Benzinga · 05/04 19:09
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3)
Benzinga · 05/04 12:10
Legal Cannabis Market Analysis 2021 : Market Size, Growth, Trends, Opportunities Forecast To 2026 with Top Countries Data
Japan, Japan, Mon, 03 May 2021 03:55:58 / Comserve Inc. / -- Competitive Analysis: Aurora Cannabis, Canopy Growth Corporation, Maricann Group, Inc., GW Pharmaceuticals, plc., Aphria, Inc., Tilray, The Cronos Group, ABcann Medicinals, Inc., Lexaria Corp., O...
Comserve · 05/03 13:11
Webull provides a variety of real-time GWPH stock news. You can receive the latest news about GW Pharma through multiple platforms. This information may help you make smarter investment decisions.
About GWPH
GW Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing therapeutics from its cannabinoid product platform in a range of disease areas. The Company's lead cannabinoid product candidate is Epidiolex, which is a liquid formulation of pure plant-derived cannabidiol (CBD). The Company offers Sativex (nabiximols), which is indicated for the treatment of spasticity due to multiple sclerosis (MS). The Company is also focused on developing its pharmaceutical product pipelines, which includes Epidiolex for the treatment of Tuberous Sclerosis Complex and RETT Syndrome.